Table 1 Baseline demographic and clinical characteristics among patients diagnosed with melanoma or chronic lymphocytic leukemia (CLL)
From: Melanoma and CLL co-occurrence and survival: role of KC history
Characteristics | Melanoman (%) | CLLn (%) | ||
|---|---|---|---|---|
All patients | Patients with KC history | All patients | Patients with KC history | |
Total sample size | 5511 | 1579 (28.7) | 571 | 113 (19.8) |
Age at diagnosis | ||||
 mean (SD) | 62.0 (15.1) | 68.4 (11.6) | 63.3 (11.2) | 69.6 (9.0) |
Age at diagnosis (categorized) | ||||
 18–29 | 168 (3.0) | 6 (0.4) | 2 (0.4) | 0 (0) |
 30–39 | 363 (6.6) | 23 (1.5) | 15 (2.6) | 0 (0) |
 40–49 | 578 (10.5) | 70 (4.4) | 41 (7.2) | 2 (1.8) |
 50–59 | 1015 (18.4) | 228 (14.4) | 149 (26.1) | 15 (13.3) |
 60–69 | 1481 (26.9) | 467 (29.6) | 177 (31.0) | 31 (27.4) |
 70–79 | 1298 (23.6) | 527 (33.4) | 154 (27.0) | 53 (46.9) |
 80 and above | 608 (11.0) | 258 (16.3) | 33 (5.8) | 12 (10.6) |
Calendar year at diagnosisa | ||||
 2009–2011/2009–2012 | 792 (14.4) | 149 (9.4) | 129 (22.6) | 12 (10.6) |
 2012–2015/2013–2015 | 2184 (39.6) | 654 (41.4) | 144 (25.2) | 33 (29.2) |
 2016–2020 | 2535 (46.0) | 776 (49.1) | 298 (52.2) | 68 (60.2) |
Sex | ||||
 Female | 2187 (39.7) | 529 (33.5) | 209 (36.6) | 33 (29.2) |
 Male | 3324 (60.3) | 1050 (66.5) | 362 (63.4) | 80 (70.8) |
Race | ||||
 American Indian | 3 (0.1) | 1 (0.1) | 0 (0) | 0 (0) |
 Asian | 8 (0.1) | 1 (0.1) | 5 (0.9) | 0 (0) |
 Black | 26 (0.5) | 1 (0.1) | 21 (3.7) | 0 (0) |
 White | 5451 (98.9) | 1571 (99.5) | 532 (93.2) | 113 (100.0) |
 Multiple races | 9 (0.2) | 3 (0.2) | 5 (0.9) | 0 (0) |
 Other | 8 (0.1) | 0 (0) | 6 (1.1) | 0 (0) |
 Unknown | 6 (0.1) | 2 (0.1) | 2 (0.4) | 0 (0) |
Ethnicity | ||||
 Non-Spanish or Hispanic origin | 5402 (98.0) | 1565 (99.1) | 540 (94.6) | 111 (98.2) |
 Spanish or Hispanic origin | 105 (1.9) | 14 (0.9) | 31 (5.4) | 2 (1.8) |
 Unknown | 4 (0.1) | 0 (0) |  |  |
Histologyb | ||||
 Desmoplastic Melanoma | 312 (5.7) | 130 (8.2) |  |  |
 Lentigo Melanoma | 341 (6.2) | 139 (8.8) |  |  |
 Melanoma Nodular | 794 (14.4) | 186 (11.8) |  |  |
 Superficial Spreading Melanoma | 2479 (45.0) | 705 (44.6) |  |  |
 Other | 1585 (28.8) | 419 (26.5) |  |  |
SEER stage at presentationc | ||||
 In situ | 3 (0.1) | 0 (0) |  |  |
 Localized | 3911 (71.0) | 1201 (76.1) |  |  |
 Regional | 1131 (20.5) | 286 (18.1) |  |  |
 Distant metastasis | 408 (7.4) | 83 (5.3) |  |  |
 Unknown/NA | 58 (1.1) | 9 (0.6) |  |  |
AJCC stage at diagnosisc | ||||
 0 | 15 (0.3) | 7 (0.4) |  |  |
 1 | 2954 (53.6) | 900 (57.0) |  |  |
 2 | 1149 (20.8) | 362 (22.9) |  |  |
 3 | 973 (17.7) | 223 (14.1) |  |  |
 4 | 333 (6.0) | 65 (4.1) |  |  |
 Unknown/NA | 87 (1.6) | 22 (1.4) |  |  |